Literature DB >> 21556310

Synthesis of dicationic diaryltriazines nucleic acid binding agents.

J Spychala1, Dw Boykin, Wd Wilson, M Zhao, Rr Tidwell, Cc Dykstra, Je Hall, Sk Jones, Rf Schinazi.   

Abstract

- The synthesis of 2,4-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-1,3,5-triazine 6a and 2,4-bis[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]-1,3,5-triazine 6b in 3 steps from either 4-bromobenzamidine or 4-(carbamoyl)benzamidine is reported. The synthesis of 4,6-bis[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-dimethylamino-1,3,5-triazine 9a and 4,6-bis[4-(1,4,5,6-tetrahydropyrimidin-2-yl)phenyl]-2-dimethylamino-1,3,5-triazine 9b in 2 steps from 1,4-dicyanobenzene is also described. The compounds 6b and 9b bind strongly to DNA model sequences and inhibit topoisomerase II from 2 microbial sources. Compounds 6a and 9a bind to both DNA and RNA model sequences whereas 6b and 9b essentially do not bind to the RNA model.

Entities:  

Year:  1994        PMID: 21556310      PMCID: PMC3058668          DOI: 10.1016/0223-5234(94)90061-2

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

1.  Isohelical analysis of DNA groove-binding drugs.

Authors:  D Goodsell; R E Dickerson
Journal:  J Med Chem       Date:  1986-05       Impact factor: 7.446

Review 2.  Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material.

Authors:  C Zimmer; U Wähnert
Journal:  Prog Biophys Mol Biol       Date:  1986       Impact factor: 3.667

3.  The search for structure-specific nucleic acid-interactive drugs: effects of compound structure on RNA versus DNA interaction strength.

Authors:  W D Wilson; L Ratmeyer; M Zhao; L Strekowski; D Boykin
Journal:  Biochemistry       Date:  1993-04-20       Impact factor: 3.162

Review 4.  DNA structure and perturbation by drug binding.

Authors:  S Neidle; L H Pearl; J V Skelly
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

5.  Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules.

Authors:  C C Dykstra; R R Tidwell
Journal:  J Protozool       Date:  1991 Nov-Dec

6.  Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats.

Authors:  R J Debs; W Blumenfeld; E N Brunette; R M Straubinger; A B Montgomery; E Lin; N Agabian; D Papahadjopoulos
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

7.  Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia.

Authors:  R R Tidwell; S K Jones; N A Naiman; L C Berger; W B Brake; C C Dykstra; J E Hall
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

8.  Structure-activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition.

Authors:  C A Bell; C C Dykstra; N A Naiman; M Cory; T A Fairley; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  Amidines; preparation of 2-substituted 4 : 5-dihydro-glyoxalines and ring homologues from cyanides and alkylenediamines.

Authors:  P OXLEY; W F SHORT
Journal:  J Chem Soc       Date:  1947-04

10.  Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.

Authors:  A B Montgomery; R J Debs; J M Luce; K J Corkery; J Turner; E N Brunette; E T Lin; P C Hopewell
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

View more
  6 in total

1.  Anti-Pneumocystis carinii pneumonia activity of dicationic 2,4-diarylpyrimidines.

Authors:  A Kumar; D Boykin; W Wilson; S Jones; B Bender; C Dykstra; J Hall; R Tidwell
Journal:  Eur J Med Chem       Date:  1996       Impact factor: 6.514

2.  Synthesis of dicationic diarylpyridines as nucleic-acid binding agents.

Authors:  A Kumar; Ra Rhodes; J Spychala; Wd Wilson; Dw Boykin; Rr Tidwell; Cc Dykstra; Je Hall; Sk Jones; Rf Schinazi
Journal:  Eur J Med Chem       Date:  1995       Impact factor: 6.514

3.  Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.

Authors:  J E Hall; J E Kerrigan; K Ramachandran; B C Bender; J P Stanko; S K Jones; D A Patrick; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  4,4'-(1,2,4,5-Tetra-zine-3,6-di-yl)dibenzo-nitrile.

Authors:  Grzegorz Dutkiewicz; Teresa Borowiak; Jarosław Spychała
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-03-25

5.  Neglected disease - african sleeping sickness: recent synthetic and modeling advances.

Authors:  Sarvesh K Paliwal; Ankita Narayan Verma; Shailendra Paliwal
Journal:  Sci Pharm       Date:  2011-05-10

Review 6.  Frameworks for targeting RNA with small molecules.

Authors:  Aline Umuhire Juru; Amanda E Hargrove
Journal:  J Biol Chem       Date:  2020-12-20       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.